Welcome to Govin Academy.... pioneers in affordable bio-education. Our aim is to provide quality training to medical students and science professionals in bioventure education, bio-entrepreneurship and biobusiness management. Govin Academy is started by Mr. Anand Govindaluri, a leading healthcare and pharmaceutical investor globally.  Govin Academy is a Singapore headquartered company that aims to be a leader in affordable bio-education for medical and science students and professionals. Its key focus is to impart innovative and cutting-edge biomedical solutions and bio-business management learning solutions to professionals with a particular focus on Asian markets.  Our aim is to build a world-class "Made in Singapore educational platform" and deliver this product to the regional and emerging markets in Asia, Asia-pacific, Japan and Africa. We will identify partners in each of the markets and will develop a unique "frugal innovation model" to impart education.  Innovation is the bedrock of a developed nation and pivotal for its growth, especially in a knowledge-based economy. Countries such as Singapore, Korea, Taiwan, Israel and China have identified new opportunities in the biomedical sciences and technology arena as the next major driver for wealth creation in the knowledge economy. They are investing heavily in life science and biotechnology-related infrastructure and capability development; in training their scientists, engineers and managers; in establishing state-of-the-art life science and technology knowledge clusters, and in putting in place policy and regulatory environments to fuel innovation and enterprise in the bio arena. The commercialization of innovation from the lab to the market isn't an easy process and requires structured training to produce efficacious - "managers of science". Those who are highly skilled individuals that understand both the market opportunity and also have a sharp knowledge of how to translate product, service and technology innovation into economic value on the other. There is also great need to understand what works and what does not in relation to driving innovation and entrepreneurship in the biomedical arena.